ARCH Venture Management, LLC Diversified Active

Location: Chicago, IL

CIK: 0001274403 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $945M (100.0% shares, 0.0% debt)

Holdings (9)

— KARUNA THERAPEUTICS, INC. 40.4%

Value $382M Shares 2,912,872 Est. Cost $131.00 Unrealized —

— EQRX, INC. 26.2%

Value $248M Shares 36,335,375 Est. Cost $6.82 Unrealized —

ERAS ERASCA, INC. 18.2%

Value $172M Shares 11,055,554 Est. Cost $17.12 Unrealized 0.0%

— VERVE THERAPEUTICS, INC. 9.8%

Value $92.5M Shares 2,508,809 Est. Cost $36.87 Unrealized —

— SINGULAR GENOMICS SYSTEMS, INC. 4.6%

Value $43.92M Shares 3,798,926 Est. Cost $11.56 Unrealized —

— RUBIUS THERAPEUTICS, INC. 0.4%

Value $3.387M Shares 349,908 Est. Cost $16.08 Unrealized —

NTRA NATERA, INC. 0.3%

Value $2.998M Shares 32,098 Est. Cost $103.78 Unrealized 0.0%

— ZYMERGEN INC. 0.1%

Value $797K Shares 119,205 Est. Cost $6.69 Unrealized —

— PULMATRIX, INC. 0.0%

Value $19,000 Shares 43,639 Est. Cost $0.44 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	KARUNA THERAPEUTICS, INC.	2,912,872	$382M	40.4%	$131.00	—	COM	48576A100
—	EQRX, INC.	36,335,375	$248M	26.2%	$6.82	—	COM	26886C107
ERAS	ERASCA, INC.	11,055,554	$172M	18.2%	$17.12	0.0%	COM	29479A108
—	VERVE THERAPEUTICS, INC.	2,508,809	$92.5M	9.8%	$36.87	—	COM	92539P101
—	SINGULAR GENOMICS SYSTEMS, INC.	3,798,926	$43.92M	4.6%	$11.56	—	COM	82933R100
—	RUBIUS THERAPEUTICS, INC.	349,908	$3.387M	0.4%	$16.08	—	COM	78116T103
NTRA	NATERA, INC.	32,098	$2.998M	0.3%	$103.78	0.0%	COM	632307104
—	ZYMERGEN INC.	119,205	$797K	0.1%	$6.69	—	COM	98985X100
—	PULMATRIX, INC.	43,639	$19,000	0.0%	$0.44	—	COM	74584P202